A PHASE 1B, MULTICENTER, OPEN-LABEL, DOSE FINDING STUDY TO INVESTIGATE THE SAFETY AND TOLERABILITY OF A SINGLE INTRAVENOUS DOSE OF SGT-501 IN PATIENTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA

Registry ID

SGT-501-101

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE1

Study type

INTERVENTIONAL

Sponsor

SOLID BIOSCIENCES, INC.

Last update

2025-06-27

Conditions

• CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA (CPVT)

Related clinical trials

• A PHASE 2, DOUBLE-BLIND, REPEAT-DOSE, PLACEBO-CONTROLLED CROSSOVER STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF CRD-4730 IN PARTICIPANTS WITH CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA

View on source registry